Author: Nicola Clementi; Elena Criscuolo; Roberta Antonia Diotti; Roberto Ferrarese; Matteo Castelli; Roberto Burioni; Massimo Clementi; Nicasio Mancini
Title: Combined prophylactic and therapeutic use maximizes hydroxychloroquine anti-SARS-CoV-2 effects in vitro Document date: 2020_3_31
ID: fhy2z49t_25
Snippet: On the contrary, a significant antiviral activity was observed in the prophylactic/therapeutic (full-time) experimental setting both at 37°C and 4°C, as evidenced both by CPE and RT-PCR analyses. This observation allows to speculate on the need of a combined prophylactic and therapeutic clinical use of HCQ on in order to maximise its antiviral effects. In the atypical scenario of an ongoing pandemic, pre-clinical medical research should be focu.....
Document: On the contrary, a significant antiviral activity was observed in the prophylactic/therapeutic (full-time) experimental setting both at 37°C and 4°C, as evidenced both by CPE and RT-PCR analyses. This observation allows to speculate on the need of a combined prophylactic and therapeutic clinical use of HCQ on in order to maximise its antiviral effects. In the atypical scenario of an ongoing pandemic, pre-clinical medical research should be focused on simple and fast observations potentially useful for the prompt set up of clinical trials. As an example, our observation could be easily translated in a clinical study on extremely high-risk categories, such as health care workers, based on the prophylactic administration of HCQ followed by its therapeutic use in case of positivity to SARS-CoV-2. The time is crucial during a pandemic and the correct clinical repurposing of HCQ could be really invaluable. author/funder. All rights reserved. No reuse allowed without permission.
Search related documents:
Co phrase search for related documents- antiviral activity and clinical study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39
- antiviral activity and clinical trial: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34
- antiviral activity and experimental set: 1, 2
- antiviral activity and health care: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
- antiviral activity and high risk: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31
- antiviral activity and medical research: 1, 2, 3
- antiviral activity and prophylactic administration: 1, 2, 3, 4, 5, 6
- antiviral activity and prophylactic therapeutic time: 1
- antiviral activity and significant antiviral activity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- antiviral activity and therapeutic time: 1, 2
- antiviral effect and clinical repurposing: 1, 2
- antiviral effect and clinical study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
- antiviral effect and clinical trial: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- antiviral effect and health care: 1, 2, 3, 4, 5, 6, 7
- antiviral effect and high risk: 1, 2, 3, 4, 5, 6, 7, 8, 9
- antiviral effect and prophylactic administration: 1
- antiviral effect and significant antiviral activity: 1, 2, 3, 4, 5, 6
- atypical scenario and high risk: 1
Co phrase search for related documents, hyperlinks ordered by date